Pancreatic metastases are rare, with a reported incidence varying from 1.6% to 11% in autopsy studies of patients with advanced malignancy. In clinical series, the frequency of pancreatic metastases ranges from 2% to 5% of all pancreatic malignant tumors. However, the pancreas is an elective site for metastases from carcinoma of the kidney and this peculiarity has been reported by several studies. The epidemiology, clinical presentation, and treatment of pancreatic metastases from renal cell carcinoma are known from singleinstitution case reports and literature reviews. There
No takes yet. Share an insight, caveat, or question.
Roberto Ballarin (2011) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: